Prepandemic Alzheimer Disease Biomarkers and Anxious-Depressive Symptoms During the COVID-19 Confinement in Cognitively Unimpaired Adults

BACKGROUND AND OBJECTIVES: Increased anxious-depressive symptomatology is observed in the preclinical stage of Alzheimer disease (AD), which may accelerate disease progression. We investigated whether β-amyloid, cortical thickness in medial temporal lobe structures, neuroinflammation, and sociodemog...

Descripción completa

Detalles Bibliográficos
Autores principales: Akinci, Muge, Peña-Gómez, Cleofé, Operto, Gregory, Fuentes-Julian, Sherezade, Deulofeu, Carme, Sánchez-Benavides, Gonzalo, Milà-Alomà, Marta, Grau-Rivera, Oriol, Gramunt, Nina, Navarro, Arcadi, Minguillón, Carolina, Fauria, Karine, Suridjan, Ivonne, Kollmorgen, Gwendlyn, Bayfield, Anna, Blennow, Kaj, Zetterberg, Henrik, Molinuevo, José Luis, Suárez-Calvet, Marc, Gispert, Juan Domingo, Arenaza-Urquijo, Eider M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576303/
https://www.ncbi.nlm.nih.gov/pubmed/35918160
http://dx.doi.org/10.1212/WNL.0000000000200948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576303/
https://www.ncbi.nlm.nih.gov/pubmed/35918160
http://dx.doi.org/10.1212/WNL.0000000000200948

Ejemplares similares